The role of immunomodulation in ABO‐incompatible adult liver transplant recipients
Journal of Clinical Apheresis2008Vol. 23(2), pp. 55–62
Citations Over TimeTop 12% of 2008 papers
Lucio Urbani, Alessandro Mazzoni, Irene Bianco, Tiziana Grazzini, Paolo De Simone, Gabriele Catalano, Umberto Montin, Stefania Petruccelli, Luca Morelli, Daniela Campani, Luca Emanuele Pollina, Gíanni Biancofiore, L Bindi, Carlo Tascini, Francesco Menichetti, Fabrizio Scatena, Franco Filipponi
Abstract
At median follow-up of 568 days, TPE in combination with IVIg and ECP appears to protect the graft from AMR in ABO-i liver transplantation. Continued patient enrollment will allow validation of these preliminary observations or the opportunity to devise newer AMR-avoidance policies.
Related Papers
- → Evaluation of cell death after treatment with extracorporeal photopheresis(2011)6 cited
- [Extracorporeal photopheresis as an alternative therapy for drug-resistant graft versus host disease: three cases].(2000)
- → Safety and Outcomes of Extracorporeal Photopheresis with the Therakos Cellex System for Graft Versus Host Disease in Pediatric Patients(2014)1 cited
- → Extracorporeal Photopheresis In Refractory Acute And/Or Chronic Graft Versus Host Disease After Allogeneic Stem Cell Transplantation(2010)
- → Extracorporeal photopheresis: The Hellenic experience(2012)